BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
215 hedge funds and large institutions have $3.9B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 85 increasing their positions, 78 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
19% less funds holding in top 10
Funds holding in top 10: 16 → 13 (-3)
33% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 33
Holders
215
Holding in Top 10
13
Calls
$95M
Puts
$45.4M
Top Buyers
| 1 | +$72.2M | |
| 2 | +$26M | |
| 3 | +$21.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.3M |
Top Sellers
| 1 | -$29.5M | |
| 2 | -$26.4M | |
| 3 | -$24.8M | |
| 4 |
CII
Capital International Inc
Los Angeles,
California
|
-$21.8M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$19.3M |